{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:35:08Z","timestamp":1792100108998,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejps.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:18:34Z","timestamp":1382660314000},"page":"200-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans"],"prefix":"10.1016","volume":"57","author":[{"given":"Christer","family":"Tannergren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Borde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Borestr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.10.001_b0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5173(01)00794-3","article-title":"Colonic metabolism of ranitidine: implications for its delivery and absorption","volume":"227","author":"Basit","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.10.001_b0010","unstructured":"Connor, A., King, G., Jones, K., 2007. Evaluation of human regional bioavailability to assess whether modified release development is feasible. In: AAPS Annual Meeting, San Diego, United States."},{"key":"10.1016\/j.ejps.2013.10.001_b0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4684-6036-0_9","article-title":"The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations","volume":"423","author":"Corrigan","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.ejps.2013.10.001_b0020","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ejps.2013.10.001_b0025","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-009-9927-x","article-title":"Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults","volume":"26","author":"Diakidou","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.10.001_b0030","series-title":"Role of the Gut Flora in Toxicity and Cancer","first-page":"22","article-title":"The bacterial flora of the intestine","author":"Drasar","year":"1988"},{"issue":"3","key":"10.1016\/j.ejps.2013.10.001_b0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/dmd.31.3.294","article-title":"Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humans","volume":"31","author":"Eriksson","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.ejps.2013.10.001_b0040","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.2042-7158.1985.tb04992.x","article-title":"Drug delivery to the proximal colon","volume":"37","author":"Hardy","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2013.10.001_b0045","first-page":"3418","article-title":"Discussion of current bacteriological investigations of the relationships between intestinal flora, diet, and colon cancer","volume":"35","author":"Moore","year":"1975","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ejps.2013.10.001_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/0148607192016005433","article-title":"Colonic fermentation of ispaghula, wheat bran, glucose, and albumin to short-chain fatty acids and ammonia evaluated in vitro in 50 subjects","volume":"16","author":"Mortensen","year":"1992","journal-title":"J. Parent. Enteral Nutr."},{"issue":"5","key":"10.1016\/j.ejps.2013.10.001_b0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejps.2007.01.005","article-title":"A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies","volume":"30","author":"Nyberg","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.001_b0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0031-6997(25)06622-0","article-title":"Metabolism of foreign compounds by gastrointestinal microorganisms","volume":"25","author":"Scheline","year":"1973","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.ejps.2013.10.001_b0065","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2013.10.001_b0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejps.2008.07.005","article-title":"Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole","volume":"35","author":"Seideg\u00e5rd","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.001_b0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0928-0987(95)00023-6","article-title":"Dextran hydrogels for colon-specific drug delivery. V. Degradation in human intestinal incubation models","volume":"3","author":"Simonsen","year":"1995","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.001_b0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Sj\u00f6berg","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2013.10.001_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the biotransformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2013.10.001_b0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/mp800261a","article-title":"Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment","volume":"6","author":"Tannergren","year":"2009","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.ejps.2013.10.001_b0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1359-6446(05)03551-8","article-title":"Assessment of the feasibility of oral controlled release in an exploratory development setting","volume":"10","author":"Thombre","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2013.10.001_b0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2011.04.028","article-title":"Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults","volume":"413","author":"Vertzoni","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.10.001_b0105","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11095-010-0223-6","article-title":"Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility","volume":"27","author":"Vertzoni","year":"2010","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.ejps.2013.10.001_b0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1461-5347(00)00311-4","article-title":"Development of a new engineering-based capsule for human drug absorption studies","volume":"3","author":"Wilding","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"8","key":"10.1016\/j.ejps.2013.10.001_b0115","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/0091270009354995","article-title":"Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans","volume":"50","author":"Zhu","year":"2010","journal-title":"J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713004065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713004065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T18:16:34Z","timestamp":1746036994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098713004065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":23,"alternative-id":["S0928098713004065"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.10.001","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}